KIMBERLY HOPKINS: Open Payments
NPI 1972116341 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 43 payments from 12 companies in 2025. Trend: 2023 $774 · 2024 $1,074 · 2025 $838
Food & beverage: $817Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $269 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $126 |
| PFIZER INC. | 5 | $99 |
| Merck Sharp & Dohme LLC | 5 | $87 |
| Amgen Inc. | 5 | $79 |
| Baxter Healthcare | 1 | $33 |
| SCPHARMACEUTICALS INC. | 2 | $31 |
| Boston Scientific Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $22 |
Products named: LEQVIO, Kerendia, ELIQUIS, REPATHA, VERQUVO, Hillrom - Carnation Ambulatory Monitor, FUROSCIX, WATCHMAN FLX.
Industry payments across TX — which companies pay providers there.
